Santiago Arroyo

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Santiago Arroyo:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BICYCLE THERAPEUTICS PLC CHIEF DEVELOPMENT OFFICER Ordinary Shares 69.1K $973K $14.09 Jan 2, 2025 Direct
MARINUS PHARMACEUTICALS INC Director Common Stock 2.75K $24.6K $8.93 Feb 4, 2022 Direct
Fulcrum Therapeutics, Inc. Chief Medical Officer Stock Option (right to buy) 400K Nov 7, 2022 Direct
BICYCLE THERAPEUTICS PLC CHIEF DEVELOPMENT OFFICER Employee Stock Option (right to buy) 87K Jan 2, 2025 Direct
BICYCLE THERAPEUTICS plc CHIEF DEVELOPMENT OFFICER Employee Stock Option (right to buy) 41.6K Feb 6, 2024 Direct
MARINUS PHARMACEUTICALS INC Director Stock Option (Right to Buy) 12.4K Feb 4, 2022 Direct
Fulcrum Therapeutics, Inc. Chief Medical Officer No securities are beneficially owned 0 Nov 7, 2022 Direct

Insider Reports Filed by Santiago Arroyo

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCYC BICYCLE THERAPEUTICS PLC Jan 2, 2025 3 -$69.6K 4 Jan 6, 2025 CHIEF DEVELOPMENT OFFICER
BCYC BICYCLE THERAPEUTICS plc Feb 6, 2024 2 $0 4 Feb 8, 2024 CHIEF DEVELOPMENT OFFICER
BCYC BICYCLE THERAPEUTICS plc Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Development Officer
BCYC BICYCLE THERAPEUTICS plc Mar 31, 2023 1 $0 4 Apr 4, 2023 Chief Development Officer
BCYC BICYCLE THERAPEUTICS plc Mar 31, 2023 0 $0 3 Apr 4, 2023 Chief Development Officer
FULC Fulcrum Therapeutics, Inc. Nov 7, 2022 1 $0 4 Nov 9, 2022 Chief Medical Officer
FULC Fulcrum Therapeutics, Inc. Nov 7, 2022 0 $0 3 Nov 9, 2022 Chief Medical Officer
MRNS MARINUS PHARMACEUTICALS INC Feb 4, 2022 2 $0 4 Feb 7, 2022 Director
MRNS MARINUS PHARMACEUTICALS INC Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
MRNS MARINUS PHARMACEUTICALS INC Jul 1, 2021 0 $0 3 Jul 1, 2021 Director